FEPI:NSD-REX FANG & Innovation Equity Premium Income ETF (USD)

ETF | Others |

Last Closing

USD 52.03

Change

+0.40 (+0.77)%

Market Cap

USD 0.06B

Volume

0.19M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

+2.20 (+1.27%)

USD 22.00B
ACWI iShares MSCI ACWI ETF

+1.32 (+1.25%)

USD 17.94B
IBIT iShares Bitcoin Trust

+1.41 (+4.35%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.07 (+0.38%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.58 (+1.13%)

USD 11.73B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.02 (+0.04%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.86B
IBTF iShares iBonds Dec 2025 Term T..

+0.02 (+0.09%)

USD 2.25B
NVDL GraniteShares 1.5x Long NVDA D..

+2.23 (+6.64%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

+0.67 (+1.13%)

USD 2.01B

ETFs Containing FEPI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.00% 22% F 44% F
Dividend Return 6.45% 98% N/A 99% N/A
Total Return 0.45% 47% F 57% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.06B 57% F 30% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike